Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04958226
Title A Study to Assess the Effect of Capivasertib on Midazolam in Patients With Advanced Solid Tumours
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors AstraZeneca

Advanced Solid Tumor


Capivasertib + Midazolam

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST